Your browser doesn't support javascript.
loading
Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.
Lee, Peter N; Abrams, David; Bachand, Annette; Baker, Gizelle; Black, Ryan; Camacho, Oscar; Curtin, Geoffrey; Djurdjevic, Smilja; Hill, Andrew; Mendez, David; Muhammad-Kah, Raheema S; Murillo, Jose Luis; Niaura, Raymond; Pithawalla, Yezdi B; Poland, Bill; Sulsky, Sandra; Wei, Lai; Weitkunat, Rolf.
Afiliación
  • Lee PN; Medical Statistics and Epidemiology, P N Lee Statistics and Computing Ltd, Sutton, Surrey, UK.
  • Abrams D; Social and Behavioral Sciences, NYU School of Public Health, New York, NY.
  • Bachand A; Health Sciences, Ramboll US Corporation, Amherst, MA.
  • Baker G; Clinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.
  • Black R; Regulatory Affairs, Altria Client Services LLC, Richmond, VA.
  • Camacho O; Computational Tools and Statistics, British American Tobacco (Investments) Ltd, Group R&D, Southampton, UK.
  • Curtin G; Scientific and Regulatory Affairs, Reynolds American Inc Services Company, Winston-Salem, NC.
  • Djurdjevic S; Clinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.
  • Hill A; Modelling, Ventana Systems UK Ltd, Salisbury, UK.
  • Mendez D; Department of Health Management and Policy School of Public Health, University of Michigan, Ann Arbor, MI.
  • Muhammad-Kah RS; Regulatory Affairs, Altria Client Services LLC, Richmond, VA.
  • Murillo JL; Regulatory Affairs, Altria Client Services LLC, Richmond, VA.
  • Niaura R; Social and Behavioral Sciences, NYU School of Public Health, New York, NY.
  • Pithawalla YB; Regulatory Affairs, Altria Client Services LLC, Richmond, VA.
  • Poland B; Strategic Consulting, Certara USA Inc, Menlo Park, CA.
  • Sulsky S; Health Sciences, Ramboll US Corporation, Amherst, MA.
  • Wei L; Regulatory Affairs, Altria Client Services LLC, Richmond, VA.
  • Weitkunat R; Clinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.
Nicotine Tob Res ; 23(3): 426-437, 2021 02 16.
Article en En | MEDLINE | ID: mdl-32496514
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Productos de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Salud Poblacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Nicotine Tob Res Asunto de la revista: SAUDE PUBLICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Productos de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Salud Poblacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Nicotine Tob Res Asunto de la revista: SAUDE PUBLICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido